Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
The XVII International AIDS Conference (AIDS 2008)
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
International News

Survey Finds Number of HIV-Positive People in China Have Become Resistant to at Least One HIV Drug

August 8, 2008

More than 17% of HIV-positive patients in 28 China provinces developed resistance to at least one available HIV/AIDS drug by 2006 and 2007, Chinese government researchers announced at the XVII International AIDS Conference in Mexico City, Reuters reports. Those who developed drug resistance tended to have low or unstable incomes, government researchers said.

According to Reuters, the finding is "surprising" because very few people had access to HIV drugs before China began a program to distribute them at no cost in 2003. In addition, HIV usually does not mutate into a drug-resistant form unless people have taken the antiretrovirals for a long period of time.

"When we first started, we didn't have much experience, and patients tended to be suspicious if these medications could work. So their adherence was not good and that resulted in higher rates of drug resistance," Liao Lingjie of the Chinese Center for Disease Control and Prevention said, adding, "People who began treatment later are responding better."

Advertisement
According to the Chinese government, about 700,000 people were living with HIV in China in 2007. Of those, about 20,000 receive antiretrovirals at no cost, official Chinese media report, Reuters reports. The World Health Organization had estimated that about 122,000 people in China would require access to antiretrovirals by the end of 2004.

Only seven of the more than 20 HIV medications are available in China, which leaves HIV-positive people in the country with limited treatment options, Reuters reports. According to Liao, officials are following up with patients who have become resistant to medications, and some will participate in clinical trials. "A small number of people are now trying out second-line drugs to see if the medication is suitable," she said (Tan, Reuters, 8/6).

Kaisernetwork.org is the official webcaster of the XVII International AIDS Conference in Mexico City. Click here to sign up for your Daily Update e-mail during the conference.

Back to other news for August 2008


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2008 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
AIDS 2008 Newsroom



Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement